MedTrace Logo

Personalised Health Recommendations to the General Population Through an Integrated AI Guided

NCT06421324 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 450

Last updated 2025-02-27

No results posted yet for this study

Summary

This clinical study aims to be used to implement and validate the AIDA tool in two phases:

* Phase 1: Risk stratification and personalised recommendations \& Model development
* Phase 2: Mechanistic Model (Bioresource) development \& testing

Conditions

  • Gastric Cancer
  • Cancer Prevention
  • Helicobacter Pylori Infection
  • Artificial Intelligence

Interventions

BEHAVIORAL

Health reccommendations

Patients are given recommendations according to their risk group, based on the model which already predicted health indicators. This information will be sent to the patient's treating physician so that treatment and recommendations are aligned with the clinical care practice based on the European Code of Cancer guidelines, the H. pylori best practices guidelines and European GIM guidelines

Sponsors & Collaborators

  • Fundación para la Investigación del Hospital Clínico de Valencia

    lead OTHER

Principal Investigators

  • Tania Fleitas, MD, PhD · Fundación para la Investigación del Hospital Clínico de Valencia

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-06-01
Primary Completion
2026-07-31
Completion
2026-12-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06421324 on ClinicalTrials.gov